Blastomycosis Treatment Market Analysis

Treatment {Medication (Itraconazole, Amphotericin B), Surgery}

The global blastomycosis treatment market is segmented and analyzed for demand and supply by treatment into medication (itraconazole, amphotericin B, and others), and surgery. Out of the two, the medication segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the increasing demand for medicines across the globe. Medical treatment for blastomycosis is done with antifungal drugs which often last for at least six months. Doctors commonly utilize itraconazole to treat mild to moderate blastomycosis, which is given 200 mg orally once or twice a day and is considered an effective treatment for immunocompetent people. Amphotericin B is generally advised for severe blastomycosis in the lungs or infections that have progressed to other body regions. Moreover, it is the only medication authorized to treat blastomycosis in expectant women. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years. Also, The growth of the segment can be attributed to the growing spending for medicines across the globe. In the United States, total prescription medication spending increased by more than 4% in 2019.

End-user (Hospital, Pharmacy)

The global blastomycosis treatment market is also segmented and analyzed for demand and supply by end-user into hospital, pharmacy, and others. Amongst these three segments, the hospital segment is expected to garner a significant share. Patients suffering from blastomycosis often visit hospitals for treatment, and it’s easier and more convenient for them to take follow-ups to check for reinfection by the fungus. In addition, the diagnosis of the disease must be identified with a high level of clinical suspicion, which is not possible at home. Further, most blastomycosis patients require therapy with prescription antifungal drugs, which are easily available in hospitals, all these factors are expected to boost the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments: